Mild cognitive impairment and Alzheimer's diagnoses trigger lower self-ratings of quality of life

August 3, 2017, Perelman School of Medicine at the University of Pennsylvania
Credit: CC0 Public Domain

Researchers at Penn Medicine have discovered that a patient's awareness of a diagnosis of cognitive impairment may diminish their self-assessment of quality of life. In a study published this month in the Journal of Gerontology: Psychological Sciences the researchers report that older adults who were aware of their diagnosis—either Mild Cognitive Impairment or mild stage Alzheimer's disease dementia—reported greater depression, higher stress, and lower quality of life than those who were unaware. They also found that older adults who had an expectation that their disease would worsen over time reported lower overall satisfaction with daily life.

"These findings suggest that a patient's quality of life could be impacted by a diagnostic label and their expectations for the prognosis. So, when a clinician discloses the and prognosis of Mild Cognitive Impairment or mild stage Alzheimer's disease, a patient may experience additional symptoms, like anxiety or depression," said the study's lead author, Shana Stites, PsyD, MA, MS, a clinical psychologist in the Penn Memory Center, senior research investigator for the Penn Project on Precision Medicine for the Brain (P3MB).

For many years, a diagnosis of Alzheimer's disease was often not made until a patient had substantial memory and - by which time patients themselves were often unaware of their diagnosis. Advances in awareness, as well in diagnostic methods, mean doctors are diagnosing Alzheimer's disease earlier, and in the future, routine diagnosis may occur before symptoms even begin. According to Stites, early diagnosis holds the promise for opportunities to prevent cognitive and functional losses and to plan for these losses. But study results show that an early diagnosis of Alzheimer's disease can also bring challenges.

The Penn Researchers studied how awareness of diagnosis impacts on self-ratings of quality of life in people with one of two disorders, Mild Cognitive Impairment—a disorder defined by slight but noticeable declines in cognitive abilities—or mild stage Alzheimer's disease dementia. They compared these ratings to a group of adults above the age of 65 with normal cognition. Study participants completed measures of multiple domains of quality of life including cognitive problems, activities of daily living, physical functioning, mental wellbeing, and perceptions of one's daily life. The researchers compared the measure of quality of life by cognitive performance, diagnosis awareness, and diagnostic group.

The findings help to identify psychological processes underlying relationships between cognitive decline and quality of life. According to Stites, the study has practical implications for current and future clinical practice.

"It's not just an issue of to tell or not to tell, it's an issue of how you tell and what you tell because when you give someone a diagnosis you're also communicating, either directly or indirectly, a lot of information that can affect the activities people do in , their planning for employment and lifestyle, emotional wellbeing, and social relationships with close friends and family members. These issues need to be explicitly addressed with patients," Stites said. "Maybe at this point we can't prevent , but we certainly have effective interventions for treating depression and for managing other symptoms."

The researchers note that further study is needed to understand what drives the impact of awareness of diagnosis and prognosis on quality of life. Future studies might include pre-clinical research that is being done in Alzheimer's disease, where clinicians are working to diagnose people who are at risk of developing the disease based on genes and biomarkers to determine how diagnosis awareness might affect an individual's sense of identity and functioning in the world if they learn that they have a high probability of developing Alzheimer's disease in the future.

A diagnosis of Alzheimer's disease can evoke assumptions, stereotypes, feelings, and attitudes that can affect a person's quality of life, how they view themselves and how they are treated by others. This study is part of the research team's ongoing efforts to understand how can impact a person's of life and wellbeing. The results add to what they've been learning about the stigma of Alzheimer's .

Explore further: Less fluent speech could be a sign of early memory problems

More information: Shana D. Stites et al. Awareness of Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia Diagnoses Associated With Lower Self-Ratings of Quality of Life in Older Adults, The Journals of Gerontology: Series B (2017). DOI: 10.1093/geronb/gbx100

Related Stories

Less fluent speech could be a sign of early memory problems

July 17, 2017
Researchers in the US have found that people with very mild memory and thinking problems also show changes in their everyday speech.

Alzheimer's drug prescribed 'off-label' for mild cognitive impairment could pose risk for some

February 24, 2017
Donepezil, a medication that is approved to treat people with Alzheimer's disease, should not be prescribed for people with mild cognitive impairment without a genetic test. UCLA School of Nursing researchers discovered that ...

Artificial intelligence may aid in Alzheimer's diagnosis

July 6, 2016
Machine learning is a type of artificial intelligence that allows computer programs to learn when exposed to new data without being programmed. Now, researchers in The Netherlands have coupled machine learning methods with ...

Is it depression or dementia? Brain SPECT imaging helps distinguish them

February 15, 2017
Does a patient have depression or a cognitive disorder (CD) such as Alzheimer's disease or both? Since both disorders have overlapping symptoms, how can a clinician tell them apart to make an appropriate diagnosis? In a new ...

Does a dementia diagnosis have a silver lining? Study suggests it can

July 25, 2016
Results from a study of patients with a diagnosis of mild cognitive impairment or early dementia indicates that their outlook isn't as dark as expected.

Quality of life and Alzheimer's assessed

August 19, 2014
A decline in cognitive functions does not necessarily mean lower health-related quality of life for people diagnosed with mild to moderate Alzheimer's disease, new research suggests.

Recommended for you

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

July 17, 2018
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic ...

New study highlights Alzheimer's herpes link, experts say

July 12, 2018
A new commentary by scientists at the Universities of Manchester and Edinburgh on a study by Taiwanese epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease.

Practice imperfect—repeated cognitive testing can obscure early signs of dementia

July 12, 2018
Alzheimer's disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

The 'Big Bang' of Alzheimer's: Scientists ID genesis of disease, focus efforts on shape-shifting tau

July 10, 2018
Scientists have discovered a "Big Bang" of Alzheimer's disease – the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.

'Skinny fat' in older adults may predict dementia, Alzheimer's risk

July 5, 2018
A new study has found that "skinny fat—the combination of low muscle mass and strength in the context of high fat mass—may be an important predictor of cognitive performance in older adults. While sarcopenia, the loss ...

Pathway of Alzheimer's degeneration discovered

July 5, 2018
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track brain degeneration in Alzheimer's disease, uncovering a pathway through which degeneration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.